This support has led to rapid acceleration of the research towards human trials. Earlier this year, Dr Woodruff’s team had expected that the earliest the first patients would trial the drug would be 2019. Now that may be as early as next year, assuming the drug is shown to be safe in preclinical testing.
Any prospective clinical trial cannot come soon enough for the hundreds of Australians diagnosed with MND each year. As researcher Dr John Lee explains, there is no known cure and the average life expectancy is only two and a half years.
“Currently the only drug available for patients prolongs survival by two to three months at most,” says Dr Lee.
Dr Lee completed his PhD in the Woodruff Laboratory, and is now an MND Research Institute of Australia Postdoctoral Fellow.
Since the FightMND funding, the drug company sponsor has scaled-up manufacture of PMX205 and undertaken formal preclinical trials. The toxicology results, together with research already published, will be presented to the US Food and Drug Administration for approval to begin administering the investigative drug in humans.
In the meantime, as Dr Woodruff explains, the School of Biomedical Sciences is testing the drug in a range of motor neurone disease models.
Dr Woodruff’s team is also identifying biomarkers in blood samples collected from patients at a Brisbane MND clinic.
“We are still investigating how the drug affects molecular processes to delay MND symptoms and extend survival,” the researcher says.
Dr Woodruff recounts the time during his student days when his fascination with the way drugs worked was piqued.
“I was in the second year of an undergraduate degree in science, and I asked my pharmacology lecturer how paracetamol worked. I’d suffered from headaches when I was younger, and taken quite a bit of it, so I was intrigued when his answer was that no one really knew.
“Researchers are yet to fully answer that question, and I often share the anecdote with my students in the hope that it will spark their curiosity too.”
This story is featured in the Summer 2017 edition of UQMedicine Magazine. View the latest edition here. Or to listen, watch, or read more stories from UQ’s Faculty of Medicine visit our content hub, MayneStream.